论文部分内容阅读
[目的]观察疏血通联合西医常规治疗脑梗塞急性期疗效。[方法]使用随机平行对照方法,将90例门诊及住院患者按就诊顺序编号法简单随机分为两组。对照组46例西医常规治疗,低分子肝素,阿司匹林,最低有效剂量为50mg或75mg/d,急性期可增加剂量至300mg/d。治疗组44例疏血通6m L+5%葡萄糖250~500m L静滴,1次/d;西医常规治疗同对照组。连续治疗2周为1疗程。观测临床症状、神经功能缺损评分(NIHSS)量表、Barthel生活能力评分量表、不良反应。治疗1疗程,判定疗效。[结果]治疗组显效21例,有效12例,无效11例,总有效率75.00%。对照组显效15例,有效15例,无效16例,总有效率65.22%。治疗组疗效优于对照组(P<0.05,P<0.01)。神经功能缺损评分及Barthel生活能力评分两组均有改善(P<0.05),治疗组改善优于对照组(P<0.05)。[结论]疏血通联合西医常规治疗脑梗塞急性期,疗效满意,无严重不良反应,值得推广。
[Objective] To observe the curative effect of Shuxuetong combined with Western routine treatment of acute cerebral infarction. [Methods] Using randomized parallel control method, 90 outpatients and inpatients were randomly divided into two groups according to the sequence numbering method. The control group of 46 cases of conventional Western medicine, low molecular weight heparin, aspirin, the lowest effective dose of 50mg or 75mg / d, acute dose can be increased to 300mg / d. The treatment group, 44 cases of Shuxuetong 6m L + 5% glucose 250 ~ 500m L intravenous infusion, 1 / d; Western conventional treatment with the control group. Continuous treatment for 2 weeks for a course of treatment. The clinical symptoms, neurological deficit score (NIHSS) scale, Barthel’s living ability scale, adverse reactions were observed. Treatment of a course of treatment to determine the efficacy. [Result] In the treatment group, 21 cases were markedly effective, 12 cases were effective, 11 cases were ineffective, and the total effective rate was 75.00%. Control group markedly effective in 15 cases, effective in 15 cases, ineffective in 16 cases, the total effective rate was 65.22%. The treatment group than the control group (P <0.05, P <0.01). Neurological deficit scores and Barthel’s viability scores improved in both groups (P <0.05), and improvement in the treatment group was better than that in the control group (P <0.05). [Conclusion] Shuxuetong combined with Western routine treatment of acute cerebral infarction, satisfactory results, no serious adverse reactions, it is worth promoting.